Sequence-specific binding of antitumour bisquaternary ammonium heterocycles to DNA and inhibition of polymerase activity in vitro.
Ten bisquaternary ammonium heterocycles (BQA) active against experimental tumours were investigated for possible sequence-selective binding to DNA. Footprinting analyses indicated that several bound preferentially to dAdT runs consisting of at least four base pairs. Shortening of one or two spacer groups between the aromatic rings of the ligands (by replacement of CONH with NH) emerged as a prerequisite for sequence-specific binding. Other relevant factors concerned the overall shape of the ligands and the relative position of their positive charges. Footprinting plots evaluated for the BQA compound SN 6132 on the 167mer EcoRI-RsaI restriction fragment from plasmid pBR322 yielded the highest individual binding constant for the symmetrical base sequence AATTTAA, with approximate K(A) = 2.0 x 10(6)/M. Polymerase-catalysed syntheses of DNA and RNA in vitro were inhibited by all BQA derivatives, but the inhibition was much more pronounced with the sequence-specific binders SN 6999 and SN 6132 than with the non-specific ligand SN 6113.
Kittler
L
L
Institut für Molekulare Biotechnologie e.V., Jena, Germany.
Wähnert
U
U
Baguley
B C
BC
Bailly
C
C
Waring
M J
MJ
Löber
G
G
D000970:Antineoplastic Agents / Q000378:metabolism* / Q000494:pharmacology; D001483:Base Sequence; D004247:DNA / Q000378:metabolism*; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D008969:Molecular Sequence Data; D019384:Nucleic Acid Synthesis Inhibitors; D000644:Quaternary Ammonium Compounds / Q000378:metabolism*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D019384:Nucleic Acid Synthesis Inhibitors; D000644:Quaternary Ammonium Compounds; D004247:DNA; D012321:DNA-Directed RNA Polymerases